Revenues in USD of Rallybio Corp from Q2 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).
Summary
Rallybio Corp quarterly/annual Revenues history and change rate from Q2 2023 to Q3 2025.
  • Rallybio Corp Revenues for the quarter ending 30 Sep 2025 was $212K, a 29.1% decline year-over-year.
  • Rallybio Corp Revenues for the twelve months ending 30 Sep 2025 was $638K.
Revenues, Trailing 12 Months (USD)
Revenues, Quarterly (USD)
Revenues, YoY Quarterly Change (%)
Revenues, Annual (USD)

Rallybio Corp Quarterly Revenues (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $638K $212K -$87K -29.1% 01 Jul 2025 30 Sep 2025 10-Q 06 Nov 2025
Q2 2025 $725K $212K -$87K -29.1% 01 Apr 2025 30 Jun 2025 10-Q 07 Aug 2025
Q1 2025 $812K $212K +$212K 01 Jan 2025 31 Mar 2025 10-Q 08 May 2025
Q4 2024 $600K $2K 01 Oct 2024 31 Dec 2024 10-K 13 Mar 2025
Q3 2024 $299K +$299K 01 Jul 2024 30 Sep 2024 10-Q 06 Nov 2025
Q2 2024 $299K +$299K 01 Apr 2024 30 Jun 2024 10-Q 07 Aug 2025
Q1 2024 $0 01 Jan 2024 31 Mar 2024 10-Q 08 May 2025
Q3 2023 $0 01 Jul 2023 30 Sep 2023 10-Q 07 Nov 2024
Q2 2023 $0 01 Apr 2023 30 Jun 2023 10-Q 08 Aug 2024

Rallybio Corp Annual Revenues (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $600K 01 Jan 2024 31 Dec 2024 10-K 13 Mar 2025
* An asterisk sign (*) next to the value indicates that the value is likely invalid.